GOOGLE · TRT & HORMONE

Advertising TRT on Google Ads: 2026 certification & restricted-term rules

Requires certification Updated June 2026 Verify against live policy
The short answerTRT is among the most-disapproved categories on Google. Testosterone is a controlled, prescription substance, so online prescribing/dispensing needs LegitScript + Google’s Prescription drug services certification, and naming “testosterone” or hormone drugs triggers the Restricted drug terms policy (US/CA/NZ; keyword-targeting needs certification). Prohormone “test boosters” are prohibited outright.

Certification & authorization

Online prescribing/dispensing requires LegitScript + Google Prescription drug services certification (industry consensus - Google has no clause literally naming “TRT”; verify). Naming testosterone/hormone drugs triggers Restricted drug terms; keyword-targeting them needs certification.

What’s prohibited

  • Sexual-enhancement or performance claims tied to hormones
  • Equivalence claims for OTC “test boosters”
  • Prohormones / anabolics (on the unapproved-substances list)
  • Unproven disease-treatment claims
  • Personalized-ad targeting (“your low T”, “your symptoms”)

Disclaimers & landing-page requirements

RequirementsGate prescribing behind a licensed medical evaluation and lab testing; clearly identify the certified entity; provide no “buy testosterone without prescription” path; substantiate any non-enhancement claims.

Top reasons ads get rejected

  • Naming testosterone/hormone drugs without certification
  • Online prescribing without LegitScript + Google certification
  • Sexual-enhancement or muscle-building claims
  • OTC “test boosters” implying Rx equivalence
  • Personalized-health targeting

What enforcement actually looks like

The word “testosterone” in a headline or keyword is the trigger: without certification it draws a restricted-drug-terms disapproval, and because Search accounts typically run many RSA variants, one policy hit tends to arrive as a batch of disapprovals at once. The escalation to avoid is the workaround reflex - misspellings, spaced-out letters, or the drug name rendered in image text are read as circumventing systems, a violation class where Google suspends the account rather than the ad, and reinstatement is rare.

How compliant brands still advertise

The compliant pathLegitScript-certify if prescribing, then Google-certify; geo-target US/CA; advertise “low testosterone treatment”, “bioidentical hormone therapy”, or “men’s health clinic” as brand-agnostic condition education; gate behind a licensed consult + labs; keep drug names off keywords unless certified.

This page covers Google policy only. For CAC benchmarks, funnel structure, and creative strategy across the whole vertical, see TRT & hormone marketing: the full vertical playbook.

FAQ

Yes, but it’s heavily restricted: prescribing needs LegitScript + Google certification, “testosterone” triggers restricted-term rules, and you advertise the condition/evaluation (“low testosterone treatment”, “men’s health clinic”) rather than the drug, gated behind a licensed consult and labs.

Not if they imply Rx equivalence or contain prohormones/anabolics - those are on Google’s unapproved-substances list. Enhancement claims tied to hormones are also disapproved.

Sources

Ad policies change frequently and enforcement is tightening - treat this as a starting point and confirm current requirements against each platform’s live policy and qualified counsel before launching. This is general information, not legal advice.

Launching trt & hormone ads on Google?

We pre-clear every account and creative against Google's health-vertical policy so your launch doesn't get rejected or your account disabled.

Book a free strategy call
30 minutes Free account audit Written plan either way
Book a free strategy call